{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:56:55Z","timestamp":1787111815010,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010659","name":"Erasmus Universitair Medisch Centrum Rotterdam","doi-asserted-by":"publisher","award":["2020-20208"],"award-info":[{"award-number":["2020-20208"]}],"id":[{"id":"10.13039\/501100010659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Complex regional pain syndrome (CRPS) is a chronic pain condition of an extremity. While achieving pain relief in CRPS is challenging, esketamine infusions can accomplish pain relief for several weeks post-infusion in a subgroup of CRPS patients. Unfortunately, CRPS esketamine protocols are very heterogeneous in advice on dosage, administration and treatment setting. Currently, no trials are available that study differences between intermittent and continuous esketamine infusions for CRPS. With the current situation of bed shortages, it is difficult to admit patients for several consecutive days for inpatient esketamine treatments. In this study, we investigate whether 6 intermittent outpatient esketamine treatments are not inferior to a continuous 6-day inpatient esketamine treatment in establishing pain relief. In addition, several secondary study parameters will be assessed in order to investigate mechanisms responsible for pain relief by esketamine infusions. Furthermore, the cost-effectiveness will be analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this RCT, the primary objective is to demonstrate that an intermittent esketamine dosing regimen is non-inferior to a continuous esketamine dosing regimen at 3\u2009months follow-up. We will include 60 adult CRPS patients. The inpatient treatment group receives a continuous intravenous esketamine infusion for 6 consecutive days. The outpatient treatment group receives a 6-hour intravenous esketamine infusion every 2\u2009weeks for 3\u2009months. Esketamine dose will be individually tailored and is started at 0.05\u2009mg\/kg\/h and can be increased to a maximum of 0.2\u2009mg\/kg\/h. Each patient will be followed for 6\u2009months. The primary study parameter is perceived pain intensity, measured by an 11-point Numerical Rating Scale. Secondary study parameters are conditioned pain modulation, quantitative sensory testing, adverse events, thermography, blood inflammatory parameter, questionnaires about functionality, quality of life and mood and costs per patient.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>If our study reveals non-inferiority between intermittent and continuous esketamine infusions, these findings can be beneficial to increase the availability and flexibility of esketamine infusions through outpatient treatments. Furthermore, the costs of outpatient esketamine infusions could be lower than inpatient esketamine infusions. In addition, secondary parameters may predict response to esketamine treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov Identifier <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05212571\">NCT05212571<\/jats:ext-link>, date of registration 01-28-2022.<\/jats:p>\n                <jats:p>Protocol version: Version 3, February 2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-023-06258-4","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T05:02:39Z","timestamp":1680066159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intermittent versus continuous esketamine infusions for long-term pain modulation in complex regional pain syndrome: protocol of a randomized controlled non-inferiority study\u00a0(KetCRPS-2)"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8302-6991","authenticated-orcid":false,"given":"Thomas J. P.","family":"Mangnus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Dirckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna D.","family":"Bharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Baart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora A. M.","family":"Siepman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Redekop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Dik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile C.","family":"de Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J. P. M.","family":"Huygen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"6258_CR1","unstructured":"Classification of chronic pain, Second Edition (revised) IASP Task Force on Taxonomy. https:\/\/www.iasp-pain.org\/publications\/free-ebooks\/classification-of-chronic-pain-second-edition-revised\/.\u00a0Accessed 1 Mar 2022."},{"issue":"2","key":"6258_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1533-2500.2009.00262.x","volume":"9","author":"M de Mos","year":"2009","unstructured":"de Mos M, Sturkenboom MC, Huygen FJ. Current understandings on complex regional pain syndrome. Pain Pract. 2009;9(2):86\u201399.","journal-title":"Pain Pract"},{"key":"6258_CR3","doi-asserted-by":"crossref","unstructured":"Mangnus TJP, Bharwani KD, Dirckx M, Huygen FJPM. From a symptom-based to a mechanism-based Pharmacotherapeutic treatment in complex regional pain syndrome. Drugs. 2022.","DOI":"10.1007\/s40265-022-01685-4"},{"issue":"9","key":"6258_CR4","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","volume":"55","author":"MA Peltoniemi","year":"2016","unstructured":"Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55(9):1059\u201377.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"6258_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1515\/sjpain-2021-0079","volume":"22","author":"TJP Mangnus","year":"2022","unstructured":"Mangnus TJP, Bharwani KD, Stronks DL, Dirckx M, Huygen F. Ketamine therapy for chronic pain in the Netherlands: a nationwide survey. Scand J Pain. 2022;22(1):97\u2013105.","journal-title":"Scand J Pain"},{"issue":"2","key":"6258_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/17512433.2020.1717947","volume":"13","author":"Y Yang","year":"2020","unstructured":"Yang Y, Maher DP, Cohen SP. Emerging concepts on the use of ketamine for chronic pain. Expert Rev Clin Pharmacol. 2020;13(2):135\u201346.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"6258_CR7","first-page":"47","volume":"62","author":"S Loix","year":"2011","unstructured":"Loix S, De Kock M, Henin P. The anti-inflammatory effects of ketamine: state of the art. Acta Anaesthesiol Belg. 2011;62(1):47\u201358.","journal-title":"Acta Anaesthesiol Belg"},{"issue":"1","key":"6258_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1515\/tnsci-2020-0167","volume":"12","author":"Z Nan","year":"2021","unstructured":"Nan Z, Lihua Y, Peilin W, Zhongchun L. Immunoregulation and antidepressant effect of ketamine. Transl Neurosci. 2021;12(1):218\u201336.","journal-title":"Transl Neurosci"},{"issue":"Suppl 3","key":"6258_CR9","first-page":"252","volume":"31","author":"LP Szalach","year":"2019","unstructured":"Szalach LP, Lisowska KA, Slupski J, Wlodarczyk A, Gorska N, Szarmach J, et al. The immunomodulatory effect of ketamine in depression. Psychiatr Danub. 2019;31(Suppl 3):252\u20137.","journal-title":"Psychiatr Danub"},{"issue":"2","key":"6258_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11916-018-0664-x","volume":"22","author":"J Zhao","year":"2018","unstructured":"Zhao J, Wang Y, Wang D. The effect of ketamine infusion in the treatment of complex regional pain syndrome: a systemic review and Meta-analysis. Curr Pain Headache Rep. 2018;22(2):12.","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"6258_CR11","doi-asserted-by":"publisher","first-page":"e18910","DOI":"10.7759\/cureus.18910","volume":"13","author":"A Chitneni","year":"2021","unstructured":"Chitneni A, Patil A, Dalal S, Ghorayeb JH, Pham YN, Grigoropoulos G. Use of Ketamine Infusions for Treatment of Complex Regional Pain Syndrome: A Systematic Review. Cureus. 2021;13(10):e18910. https:\/\/doi.org\/10.7759\/cureus.18910.","journal-title":"Cureus."},{"key":"6258_CR12","volume-title":"Updated guidelines complex regional pain syndrome type 1","author":"R Perez","year":"2014","unstructured":"Perez R, Geertzen JHB, Dijkstra PU, Dirckx M, Van Eijs F, Fr\u00f6lke JP. Updated guidelines complex regional pain syndrome type 1. Utrecht: The Dutch Pain Society; 2014."},{"issue":"8","key":"6258_CR13","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/papr.13056","volume":"21","author":"TJP Mangnus","year":"2021","unstructured":"Mangnus TJP, Dirckx M, Bharwani KD, de Vos CC, Frankema SPG, Stronks DL, et al. Effect of intravenous low-dose S-ketamine on pain in patients with complex regional pain syndrome: a retrospective cohort study. Pain Pract. 2021;21(8):890\u20137.","journal-title":"Pain Pract"},{"issue":"3","key":"6258_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.pain.2010.09.031","volume":"151","author":"NR Harden","year":"2010","unstructured":"Harden NR, Bruehl S, Perez R, Birklein F, Marinus J, Maihofner C, et al. Development of a severity score for CRPS. Pain. 2010;151(3):870\u20136.","journal-title":"Pain"},{"issue":"9","key":"6258_CR15","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1097\/j.pain.0000000000002245","volume":"162","author":"A Goebel","year":"2021","unstructured":"Goebel A, Birklein F, Brunner F, Clark JD, Gierthmuhlen J, Harden N, et al. The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria. Pain. 2021;162(9):2346\u20138.","journal-title":"Pain"},{"issue":"5","key":"6258_CR16","first-page":"521","volume":"43","author":"SP Cohen","year":"2018","unstructured":"Cohen SP, Bhatia A, Buvanendran A, Schwenk ES, Wasan AD, Hurley RW, et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of pain medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):521\u201346.","journal-title":"Reg Anesth Pain Med"},{"issue":"3","key":"6258_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, Hr\u00f3bjartsson A, Mann H, Dickersin K, Berlin JA, Dor\u00e9 CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137. https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583.","journal-title":"Ann Intern Med."},{"key":"6258_CR18","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"issue":"6","key":"6258_CR19","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/j.pain.0000000000000866","volume":"158","author":"S Grieve","year":"2017","unstructured":"Grieve S, Perez R, Birklein F, Brunner F, Bruehl S, Harden RN, et al. Recommendations for a first Core outcome measurement set for complex regional PAin syndrome clinical sTudies (COMPACT). Pain. 2017;158(6):1083\u201390.","journal-title":"Pain"},{"issue":"24","key":"6258_CR20","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1097\/00007632-200012150-00012","volume":"25","author":"PL Hudak","year":"2000","unstructured":"Hudak PL, Wright JG. The characteristics of patient satisfaction measures. Spine (Phila Pa 1976). 2000;25(24):3167\u201377.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"10","key":"6258_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"3","key":"6258_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.pain.2009.06.023","volume":"145","author":"MJ Sigtermans","year":"2009","unstructured":"Sigtermans MJ, van Hilten JJ, Bauer MCR, Arbous SM, Marinus J, Sarton EY, et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain. 2009;145(3):304\u201311.","journal-title":"Pain"},{"issue":"9","key":"6258_CR23","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.pain.2011.03.026","volume":"152","author":"IM Noppers","year":"2011","unstructured":"Noppers IM, Niesters M, Aarts L, Bauer MCR, Drewes AM, Dahan A, et al. Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases. Pain. 2011;152(9):2173\u20138.","journal-title":"Pain"},{"issue":"1","key":"6258_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejpain.2005.02.003","volume":"10","author":"R Rolke","year":"2006","unstructured":"Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, et al. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain. 2006;10(1):77\u201388.","journal-title":"Eur J Pain"},{"issue":"11","key":"6258_CR25","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1097\/j.pain.0000000000000689","volume":"157","author":"DL Kennedy","year":"2016","unstructured":"Kennedy DL, Kemp HI, Ridout D, Yarnitsky D, Rice ASC. Reliability of conditioned pain modulation: a systematic review. Pain. 2016;157(11):2410\u20139.","journal-title":"Pain"},{"key":"6258_CR26","doi-asserted-by":"publisher","first-page":"2764261","DOI":"10.1155\/2017\/2764261","volume":"2017","author":"KD Bharwani","year":"2017","unstructured":"Bharwani KD, Dirckx M, Stronks DL, Dik WA, Schreurs MWJ, Huygen F. Elevated plasma levels of sIL-2R in complex regional pain syndrome: a pathogenic role for T-lymphocytes? Mediat Inflamm. 2017;2017:2764261.","journal-title":"Mediat Inflamm"},{"issue":"5","key":"6258_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s40291-019-00417-x","volume":"23","author":"KD Bharwani","year":"2019","unstructured":"Bharwani KD, Dik WA, Dirckx M, Huygen F. Highlighting the role of biomarkers of inflammation in the diagnosis and Management of Complex Regional Pain Syndrome. Mol Diagn Ther. 2019;23(5):615\u201326.","journal-title":"Mol Diagn Ther"},{"issue":"5","key":"6258_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00421-003-1037-6","volume":"91","author":"FJPM Huygen","year":"2004","unstructured":"Huygen FJPM, Niehof S, Klein J, Zijlstra FJ. Computer-assisted skin videothermography is a highly sensitive quality tool in the diagnosis and monitoring of complex regional pain syndrome type I. Eur J Appl Physiol. 2004;91(5):516\u201324.","journal-title":"Eur J Appl Physiol"},{"issue":"6","key":"6258_CR29","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s11136-013-0611-6","volume":"23","author":"CB Terwee","year":"2014","unstructured":"Terwee CB, Roorda LD, de Vet HC, Dekker J, Westhovens R, van Leeuwen J, Cella D, Correia H, Arnold B, Perez B, Boers M. Dutch-Flemish translation of 17 item banks from the patient-reported outcomes measurement information system (PROMIS). Qual Life Res. 2014;23(6):1733\u201341. https:\/\/doi.org\/10.1007\/s11136-013-0611-6.","journal-title":"Qual Life Res."},{"issue":"1-2","key":"6258_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pain.2009.02.007","volume":"144","author":"RH Dworkin","year":"2009","unstructured":"Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, et al. Development and initial validation of an expanded and revised version of the short-form McGill pain questionnaire (SF-MPQ-2). Pain. 2009;144(1-2):35\u201342.","journal-title":"Pain"},{"issue":"4","key":"6258_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","volume":"7","author":"MJL Sullivan","year":"1995","unstructured":"Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524.","journal-title":"Psychol Assess"},{"issue":"2","key":"6258_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejpain.2005.12.008","volume":"11","author":"MK Nicholas","year":"2007","unstructured":"Nicholas MK. The pain self-efficacy questionnaire: taking pain into account. Eur J Pain. 2007;11(2):153\u201363.","journal-title":"Eur J Pain"},{"issue":"4","key":"6258_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ejpain.2005.06.006","volume":"10","author":"HCJL Buscher","year":"2006","unstructured":"Buscher HCJL, Wilder-Smith OHG, van Goor H. Chronic pancreatitis patients show hyperalgesia of central origin: a pilot study. Eur J Pain. 2006;10(4):363\u201370.","journal-title":"Eur J Pain"},{"issue":"2","key":"6258_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.pain.2010.02.026","volume":"149","author":"AIM van Laarhoven","year":"2010","unstructured":"van Laarhoven AIM, Kraaimaat FW, Wilder-Smith OH, van de Kerkhof PCM, Evers AWM. Heterotopic pruritic conditioning and itch \u2013 analogous to DNIC in pain? PAIN\u00ae. 2010;149(2):332\u20137.","journal-title":"PAIN\u00ae"},{"issue":"1","key":"6258_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neurom.2022.06.009","volume":"26","author":"N Kriek","year":"2023","unstructured":"Kriek N, de Vos CC, Groeneweg JG, Baart SJ, Huygen FJPM. Allodynia, Hyperalgesia, (Quantitative) Sensory Testing and Conditioned Pain Modulation in Patients With Complex Regional Pain Syndrome Before and After Spinal Cord Stimulation Therapy. Neuromodulation. 2023;26(1):78\u201386. https:\/\/doi.org\/10.1016\/j.neurom.2022.06.009.","journal-title":"Neuromodulation."},{"issue":"6","key":"6258_CR36","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/ejp.605","volume":"19","author":"D Yarnitsky","year":"2015","unstructured":"Yarnitsky D, Bouhassira D, Drewes AM, Fillingim RB, Granot M, Hansson P, et al. Recommendations on practice of conditioned pain modulation (CPM) testing. Eur J Pain. 2015;19(6):805\u20136.","journal-title":"Eur J Pain"},{"issue":"3","key":"6258_CR37","doi-asserted-by":"publisher","first-page":"e57963","DOI":"10.1371\/journal.pone.0057963","volume":"8","author":"SS Olesen","year":"2013","unstructured":"Olesen SS, Graversen C, Bouwense SAW, van Goor H, Wilder-Smith OHG, Drewes AM. Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis. PLoS One. 2013;8(3):e57963.","journal-title":"PLoS One"},{"issue":"5","key":"6258_CR38","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/ALN.0000000000002417","volume":"129","author":"RL Bosma","year":"2018","unstructured":"Bosma RL, Cheng JC, Rogachov A, Kim JA, Hemington KS, Osborne NR, et al. Brain dynamics and temporal summation of pain predicts neuropathic pain relief from ketamine infusion. Anesthesiology. 2018;129(5):1015\u201324.","journal-title":"Anesthesiology"},{"issue":"6","key":"6258_CR39","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/bja\/aes578","volume":"110","author":"M Niesters","year":"2013","unstructured":"Niesters M, Aarts L, Sarton E, Dahan A. Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept study. Br J Anaesth. 2013;110(6):1010\u20136.","journal-title":"Br J Anaesth"},{"issue":"7","key":"6258_CR40","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/AJP.0000000000000831","volume":"36","author":"AF Kirkpatrick","year":"2020","unstructured":"Kirkpatrick AF, Saghafi A, Yang K, Qiu P, Alexander J, Bavry E, et al. Optimizing the treatment of CRPS with ketamine. Clin J Pain. 2020;36(7):516\u201323.","journal-title":"Clin J Pain"},{"key":"6258_CR41","volume-title":"Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg","author":"L Hakkaart-van Roijen","year":"2016","unstructured":"Hakkaart-van Roijen L, Van der Linden N, Bouwmans C, Kanters T, Tan S. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg. Diemen: Zorginstituut Nederland; 2016."},{"issue":"2","key":"6258_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1213\/ANE.0000000000001787","volume":"124","author":"DP Maher","year":"2017","unstructured":"Maher DP, Chen L, Mao J. Intravenous ketamine infusions for neuropathic pain management: a promising therapy in need of optimization. Anesth Analg. 2017;124(2):661\u201374.","journal-title":"Anesth Analg"},{"issue":"2","key":"6258_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1526-4637.2011.01241.x","volume":"13","author":"S Patil","year":"2012","unstructured":"Patil S, Anitescu M. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis. Pain Med. 2012;13(2):263\u20139.","journal-title":"Pain Med"},{"issue":"1-3","key":"6258_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pain.2009.08.015","volume":"147","author":"RJ Schwartzman","year":"2009","unstructured":"Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain. 2009;147(1-3):107\u201315.","journal-title":"Pain"},{"issue":"1","key":"6258_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-015-0515-4","volume":"15","author":"KA Sheehy","year":"2015","unstructured":"Sheehy KA, Muller EA, Lippold C, Nouraie M, Finkel JC, Quezado ZMN. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study. BMC Pediatr. 2015;15(1):1\u20138.","journal-title":"BMC Pediatr"},{"issue":"14","key":"6258_CR46","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1517\/14656566.2010.515978","volume":"11","author":"I Noppers","year":"2010","unstructured":"Noppers I, Niesters M, Aarts L, Smith T, Sarton E, Dahan A. Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother. 2010;11(14):2417\u201329.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"6258_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/pm\/pny024","volume":"20","author":"J Xu","year":"2019","unstructured":"Xu J, Herndon C, Anderson S, Getson P, Foorsov V, Harbut RE, et al. Intravenous ketamine infusion for complex regional pain syndrome: survey, consensus, and a reference protocol. Pain Med. 2019;20(2):323\u201334.","journal-title":"Pain Med"},{"issue":"2-3","key":"6258_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tacc.2014.03.002","volume":"4","author":"J Sleigh","year":"2014","unstructured":"Sleigh J, Harvey M, Voss L, Denny B. Ketamine\u2013More mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4(2-3):76\u201381.","journal-title":"Trends Anaesth Crit Care"},{"issue":"12","key":"6258_CR49","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/17425255.2019.1689958","volume":"15","author":"J Kamp","year":"2019","unstructured":"Kamp J, Van Velzen M, Olofsen E, Boon M, Dahan A, Niesters M. Pharmacokinetic and pharmacodynamic considerations for NMDA-receptor antagonist ketamine in the treatment of chronic neuropathic pain: an update of the most recent literature. Expert Opin Drug Metab Toxicol. 2019;15(12):1033\u201341.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"6258_CR50","doi-asserted-by":"publisher","first-page":"174480691879912","DOI":"10.1177\/1744806918799127","volume":"14","author":"J David Clark","year":"2018","unstructured":"David Clark J, Tawfik VL, Tajerian M, Kingery WS. Autoinflammatory and autoimmune contributions to complex regional pain syndrome. Mol Pain. 2018;14:1744806918799127.","journal-title":"Mol Pain"},{"issue":"1","key":"6258_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12974-021-02245-5","volume":"18","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Wang C, Lan X, Li H, Chao Z, Ning Y. Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine. J Neuroinflammation. 2021;18(1):200.","journal-title":"J Neuroinflammation"},{"key":"6258_CR52","doi-asserted-by":"publisher","first-page":"100383","DOI":"10.1016\/j.bbih.2021.100383","volume":"18","author":"N Nikkheslat","year":"2021","unstructured":"Nikkheslat N. Targeting inflammation in depression: ketamine as an anti-inflammatory antidepressant in psychiatric emergency. Brain Behav Immun Health. 2021;18:100383.","journal-title":"Brain Behav Immun Health"},{"issue":"5","key":"6258_CR53","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrneurol.2018.20","volume":"14","author":"F Birklein","year":"2018","unstructured":"Birklein F, Ajit SK, Goebel A, Perez R, Sommer C. Complex regional pain syndrome - phenotypic characteristics and potential biomarkers. Nat Rev Neurol. 2018;14(5):272\u201384.","journal-title":"Nat Rev Neurol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06258-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-023-06258-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06258-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T06:04:48Z","timestamp":1680069888000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-023-06258-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6258"],"URL":"https:\/\/doi.org\/10.1186\/s12891-023-06258-4","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Medical Ethics Committee of Erasmus University Medical Center Rotterdam (MEC-2021-0426). Informed consent will be obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest that are relevant or related to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}